Evidence map›Paper›PMID 39235167›Full record

Observational studyThe Journal of dermatology2024

Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.

Saori Uesugi-Uchida, Manabu Fujimoto, Yoshihide Asano, Hirahito Endo, Daisuke Goto, Masatoshi Jinnin, Yasushi Kawaguchi, Sumiaki Tanaka, Takahiro Tokunaga, Katsunari Makino and 5 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Saori Uesugi-UchidaDepartment of Dermatology, University of Fukui, Fukui, Japan.
Manabu FujimotoDepartment of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yoshihide AsanoDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hirahito EndoDepartment of Rheumatology, Southern Tohoku General Hospital, Fukushima, Japan.
Daisuke GotoDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Masatoshi JinninDepartment of Dermatology, Wakayama Medical University Graduate School of Medicine, Wakayama, Japan.
Yasushi KawaguchiInstitute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
Sumiaki TanakaKitasato University Hospital, Sagamihara, Japan.
Takahiro TokunagaMedical Research Support Center, University of Fukui Hospital, Fukui, Japan.
Katsunari MakinoDepartment of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Takashi MatsushitaDepartment of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.ORCID https://orcid.org/0000-0002-1617-086X
Sei-Ichiro MotegiDepartment of Dermatology, Gunma University Graduate School of Medicine, Maebash, Gunma, Japan.ORCID https://orcid.org/0000-0001-8286-0669
Ayumi YoshizakiDepartment of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Shinichi SatoDepartment of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Minoru HasegawaDepartment of Dermatology, University of Fukui, Fukui, Japan.ORCID https://orcid.org/0000-0003-3738-2682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the clinical course of systemic sclerosis (SSc) varies widely, prognostic indicators have been sought to predict the outcomes of individual patients. Racial differences in SSc render it necessary to validate prognostic indicators in different patient cohorts. In this study, we aimed to assess clinical and laboratory parameters in Japanese patients with early-stage SSc with diffuse cutaneous involvement and/or interstitial lung disease, and identify predictive factors for disease progression. We performed multivariate analyses of baseline clinical information to estimate symptoms 4 years later in Japanese patients with diffuse cutaneous SSc and/or SSc with interstitial lung disease. Patients were enrolled in the study within 5 years of disease onset at 10 Japanese SSc centers. Over 12 years, 115 patients followed up for 4 years were included in this study. The modified Rodnan skin score (mRSS) at 4 years correlated with the baseline mRSS and finger-to-palm distance, defined as the average length from the distal tip of the fourth finger to the distal palmar crease. The percentage predicted vital capacity (%VC) in year 4 positively and negatively correlated with initial %VC and the presence of anti-topoisomerase I antibodies, respectively. The Health Assessment Questionnaire Disability Index (HAQ-DI) at 4 years was positively and negatively associated with baseline HAQ-DI and %VC, respectively. The occurrence of digital ulcers within 4 years was associated with the initial presence of digital ulcers, finger-to-palm distance, and the presence of digital pitting scars and anti-topoisomerase I antibodies. This study identified several factors that may predict the progression of early-stage SSc in Japanese patients. Finger-to-palm distance may be a useful tool for predicting the progression of skin thickening and the development of digital ulcers in the early stages of severe SSc, but larger, long-term prospective studies are needed to confirm our findings.

Indexed as

Disease ProgressionLung Diseases, InterstitialSeverity of Illness IndexAdultAge of OnsetDisability EvaluationDNA Topoisomerases, Type IEast Asian PeopleFemaleFollow-Up StudiesHumansJapanMaleMiddle AgedPrognosisProspective StudiesDNA Topoisomerases, Type Idigital ulcerhealth assessment questionnairelungpredictive factorskinsystemic sclerosis

Identifiers

PMID39235167
PMCPMC11483931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.